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osting by EAbstract Metal complexes of gliclazide (GLZ; HL) drug are prepared and characterized based on
elemental analyses, IR, diffused reﬂectance, magnetic moment, molar conductance and thermal anal-
yses (TG and DTG) technique. From the elemental analyses data, the complexes are proposed to
have the general formulae [M(HL)Cl3(H2O)]Æ3H2O (M= Cr(III) and Fe(III)), [M(HL)Cl2(H2O)2]Æ
yH2O (M= Co(III), Ni(II) and Cu(II), y= 0–2) and [M(HL)Cl2]ÆyH2O (M=Mn(II) and Zn(II),
y= 0–1). The molar conductance data reveal that all the metal chelates are non-electrolytes. IR
spectra show that GLZ is coordinated to the metal ions in a neutral bidentate manner with ON donor
sites of the amide-O and sulphonamide-OH. From the magnetic and solid reﬂectance spectra, it is
found that the geometrical structures of these complexes are octahedral (Cr(III), Fe(III), Co(II),
Ni(II) and Cu(II)) and tetrahedral (Mn(II) and Zn(II)). The thermal behaviour of these chelates is
studied using thermogravimetric analysis (TG and DTG) techniques. The results obtained show that
the hydrated complexes lose water molecules of hydration followed immediately by decomposition
of the anions and ligand molecules in the successive unseparate steps. The activation thermodynamic
parameters are calculated using Coats–Redfern method. The GLZ drug, in comparison to its
metal complexes also is screened for their biological activity against house ﬂy, Musca domesticam (M.A. Zayed).
ity. All rights reserved. Peer-
d University.
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Figure 1 Structure of G
110 G.G. Mohamed et al.(Diptera – Muscidae). Dose of 5 lg/insect of gliclazide is typically applied against 3 days-old larval
instar ofM. domestica. Survival of pupal and adult stages has been affected by the complexes of gli-
clazide more than larval instars. Morphogenic abnormalities of larvae, pupae and adults are studied.
On the other hand, pupation and adult emergence program is deteriorated by the effect of different
chemicals.
ª 2009 King Saud University. All rights reserved.1. Introduction
Currently the most commonly prescribed medications for Type
2 diabetes were metformin and the second generation sulfonylu-
reas which included glipizide, GLZ, glibenclamide and glimpe-
ride. For many patients with Type 2 diabetes, monotherapy
with an oral antidiabetic agent was not sufﬁcient to reach target
glycaemic goals and multiple drugs may be necessary to achieve
adequate control (Martha et al., 2000). In such cases, a combina-
tion of metformin and one of the sulfonylureas (SU) was used
(Tack and Smits, 1999). Themeasurement of the plasma concen-
trations of antidiabetic medications was important for studying
the pharmacokinetics of these drugs, for adherence and drug
monitoring in diabetic patients and for diagnostic purposes in
factitious hypoglycaemia. Thus, for certain diabetic populations
there could be patients who were prescribed glipizide, GLZ,
glimperide, glibenclamide, metformin or a combination of met-
formin and one of the sulfonylureas.
Several procedures had been developed to be used as stan-
dard methods for the analysis of sulfonylureas (Paroni et al.,
2000; Sved et al., 1976; Sener et al., 1995; Strausbauch et al.,
1995). However, none of these methods were suitable for rou-
tine analysis. Some of them used solvent extraction in sample
preparation (Sved et al., 1976; Sener et al., 1995; Strausbauch
et al., 1995) which is a time consuming process and loss of sam-
ple may frequently occur during extraction due to emulsion
formation. In addition to that low recovery has been reported.
There is no single published method for the simultaneous
determination of both metformin and any of the sulfonylureas
in biological ﬂuids.
A method for determination of metformin and glipizide or
GLZ (Vasudevan et al., 2001) and a method for the estimation
of metformin and glibenclamide from their combined dosage
forms (Khanolkar and Shinde, 1999) had been described previ-
ously for use in studying pharmaceutical preparations but not
for the analysis in biological ﬂuids. When studying the phar-
macokinetics of a new formulation containing a combination
of metformin and glibenclamide Martha et al. (2000) used
two separate methods, one for measuring the concentration
of metformin and the other for glibenclamide.
Many drugs possessed modiﬁed pharmacological and toxi-
cological properties when administered in the form of metallic
complexes. Probably the most widely studied cation in this re-
spect was Cu(II), since a host of low-molecular-weight Cu(II)
complexes had been proven beneﬁcial against several diseasesN
LZ (HL) drug.such as tuberculosis, rheumatoid, gastric ulcers, and cancers
(Sorenson, 1976; Ruiz et al., 1995).
However, in this work we prepare chelates of Mn(II),
Cr(III), Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) transition
metals with GLZ drug molecule. The solid chelates are charac-
terized using different physico-chemical methods like elemen-
tal analyses (C, H, N, S and metal content), IR, magnetic
moment and reﬂectance spectra, and thermal analyses (TG
and DTG). Biological activities of the complexes are studied.
The structure of GLZ drug is given in Fig. 1.2. Experimental
2.1. Materials and reagents
All chemicals used were of the analytical reagent grade (AR),
and of highest purity available. They included gliclazide (Uni-
Pharma); copper(II) chloride dihydrate (Prolabo); cobalt(II)
and nickel(II) chlorides hexahydrates (BDH); zinc(II) chloride
dihydrate (Ubichem), chromium(III) chloride hexahydrate
(Sigma); manganese(II) chloride and ferric(III) chloride hexa-
hydrate (Prolabo). Zinc oxide, disodium salt of ethylenedi-
aminetetraacetic acid; EDTA; (AnalaR), ammonia solution
(33% v/v) and ammonium chloride (El-Nasr pharm. Chem.
Co., Egypt). Organic solvents used included absolute ethyl
alcohol, diethylether, and dimethylformamide (DMF). These
solvents were spectroscopic pure from BDH. Hydrogen perox-
ide, hydrochloric and nitric acids (MERCK) were used. De-
ionized water collected from all glass equipments was usually
used in all preparations.
2.2. Instruments
The molar conductance of solid complexes in DMF was mea-
sured using Sybron–Barnstead conductometer (Meter-PM.6,
E = 3406). Elemental microanalyses of the separated solid
chelates for C, H, N and S were performed at the Microanalyt-
ical Center, Cairo University, using CHNS-932 (LECO) Vario
Elemental Analyzers. The analyses were repeated twice to
check the accuracy of the data. Infrared spectra were recorded
on a Perkin–Elmer FT-IR type 1650 spectrophotometer in
wave number region 4000–400 cm1. The spectra were re-
corded as KBr pellets.
The solid reﬂectance spectra were measured on a Shimadzu
3101pc spectrophotometer. The molar magnetic susceptibility
was measured on powdered samples using the Faraday method.
The diamagnetic corrections were made by Pascal’s constant
and Hg[Co(SCN)4] was used as a calibrant. The thermogravi-
metric (TG and DTG) analysis was carried out in dynamic
nitrogen atmosphere (20 mL min1) with a heating rate of
10 C min1 using Shimadzu TGA-50H thermal analyzer.
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Metal complexes of gliclazide: Preparation, spectroscopic and thermal characterization 1112.3. Synthesis of metal complexes
The metal complexes were prepared by the addition of hot
solution (60 C) of the appropriate metal chloride salts
(1 mmol) in an ethanol–water mixture (1:1, 25 mL) to the
hot solution (60 C) of GLZ (0.4 g, 1 mmol) in the same sol-
vent (25 mL). The resulting mixture was stirred under reﬂux
for 1 h whereupon the complexes precipitated. They were col-
lected by ﬁltration, washed with a 1:1 ethanol:water mixture
and diethyl ether. The analytical data for C, H, N and S were
repeated twice.
2.4. Determination of the metal content of the chelates
An accurately weighed portion of the different chelates ran-
ged from 10 to 30 mg was placed in Kjeldahl ﬂask. A mea-
sured volume of concentrated nitric acid ranged from 5 to
10 mL was added initially to the powdered chelates, to start
the fast wet oxidation digestion. This mixture had been di-
gested with some drops of H2O2 solution using a gradual
heating. This treatment was conducted until most of the
powdered complexes were diminished and the remained solu-
tion had the colour of the corresponding metal salt. This
solution was then diluted up to a 50 mL with bidistilled
water and the metal content was determined by titration
against standard EDTA solution at a suitable pH value
using the suitable indicator.
2.5. Biological activity
In the present study, the larvae of Musca domestica were col-
lected from the permanent colony of insect colony of Entomol-
ogy Department, Faculty of Science, Cairo University. Insect
were reared in the laboratory according to the method of
Nassar (1988) with some modiﬁcation.
2.6. Bioassay and statistical analysis
Larval mortalities were observed during the larval period,
while pupal and adult mortalities were calculated based on
the successfully emerged individuals from the treated larvae.
The developmental rates were also studied. Data obtained
were analyzed by the Student’s t-distribution and reﬁned by
Bessel correction (Moroney, 1956).T
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R3. Results and discussion
The formation of metal complexes with organic compounds
has long been recognized. However, the binary complexes of
the cited drug with metal ions have not been studied yet,
although they may be an area of interest. This is because they
may affect the bioavailability of these drugs as certain metal
ions were present in relatively appreciable concentration in
biological ﬂuids (Salama et al., 2003).
3.1. Composition and structures of metal complexes
The isolated solid complexes of Cr(III), Mn(II), Fe(III), Co(II),
Ni(II), Cu(II) and Zn(II) ions with the GLZ ligand are sub-
112 G.G. Mohamed et al.jected to elemental analyses (C, H, N, S and metal content), IR,
magnetic moment studies, molar conductance and thermal
analyses (TG and DTG), to identify their tentative formulae
in a trial to elucidate their molecular structures. The results
of elemental analyses listed in Table 1 suggest the formulae
[M(HL)Cl3(H2O)]Æ3H2O (M= Cr(III) and Fe(III)), [M(HL)-
Cl2(H2O)2]ÆyH2O (M= Co(III), Ni(II) and Cu(II), y= 0–2)
and [M(HL)Cl2]ÆyH2O (M=Mn(II) and Zn(II), y= 0–1).
3.2. Molar conductivity measurements
The chelates are dissolved in DMF and the molar conductivi-
ties of 103 M of their solutions at 25 C are measured. It is
concluded from the results listed in Table 1 that the chelates
are found to have molar conductance values of 13.20–CH3
S
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(i) (ii)
(iii)(iv)30.10 X1 mol1 cm2 indicating that all the metal chelates are
non-electrolytes.
3.3. IR spectral studies
The IR data of the spectra of GLZ ligand and its complexes
are listed in Table 2. The IR spectra of the complexes are com-
pared with those of the free GLZ ligand in order to determine
the coordination sites that may be involved in chelation. The
tautomeric equilibrium depends on the extent of conjugation,
nature and position of the substituents, polarity of the solvent
etc.
This phenomenon has drawn considerable attention by sev-
eral investigators and characteristic spectral bands have been
assigned to the individual tautomers. As an example, Fig. 2
shows the IR spectrum of Zn(II) complex.Table 2 IR spectra (4000–400 cm1) of the GLZ ligand and its me
Compound m(OH) Enolic m(NH) m(SO2) Asy
GLZ;HL 3100–3400br – 1375sh
[Cr(HL)Cl3(H2O)]Æ3H2O 3150–3400br 3047br 1404sh
[Mn(HL)Cl2]ÆH2O 3200–3370br 3150br 1405sh
[Fe(HL)Cl3(H2O)]Æ3H2O 3150–3400br 3045br 1399m
[Co(HL)Cl2(H2O)2] 3150–3400br 3045br 1410m
[Ni(HL)Cl2(H2O)2]Æ2H2O 3170–3370br 3052br 1408sh
[Cu(HL)Cl2(H2O)2] 3200–3300br 3105br 1403m
[Zn(HL)Cl2] 3170–3450br 3059 1403m
sh = sharp, m = medium, s = small, w = weak, br = broad.The sharp band at 1640 cm1 can be assigned to the amide
carbonyl of the saturated side chain moiety. A broad band
spreading over the region 3400–3100 cm1 can be ascribed to
NH groups. Some authors have reported that the amide
carbonyl group present in the saturated side chain moiety
enolises. However, the strong a-effect due to heterocyclic
nitrogen atom on the saturated side chain moiety prevents the
enolization of this carbonyl group. The complexes under inves-
tigation have a band near 3150–3045 cm1, which is due to the
N–Hstretching of the saturated side chainmoietywhich support
the presence of the amide NH in the keto form (ii) and not in the
enol form (iii) (Yao and Resnick, 1962). This band is masked
with a very broadband in the region 3500–3000 cm1 in the spec-
tra of the complexes under investigationwhichmaybe due to the
intermolecular hydrogen bonding in the solid state.The stretching vibration band; m(NH), of the sulfonamide group
in the free ligand is hidden under the peak of water molecules or
due to the enolization. The presence of coordinated water mol-
ecules renders it difﬁcult to conﬁrm the enolization of the sulfon-
amide group. The SO2 group modes of the GLZ drug appear as
sharp bands at 1375 and 1100 cm1 due to masym(SO2) and msym(-
SO2), respectively. In the complexes, the asymmetric and sym-
metric modes are shifted to 1399–1410 and 1125–1160 cm1,
respectively, upon coordination to the metal ions (Mohamed
and Abd El-Wahwb, 2003; Raman et al., 2001). The shift of
the SO2 stretching vibration to higher frequencies may be attrib-
uted to the transformation of the sulfonamide (SO2NH) to give
the enol form (SO(OH)N) as a result of complex formation to
give more stable six-membered ring (Mohamed and Abd El-
Wahwb, 2003; Raman et al., 2001; Kolwalkar and Mehta,
1996). The IR bands at 815–855 and 752–770 cm1, t(H2O) of
coordinated water, is an indication of the binding of the watertal complexes.
m. m(SO2) Sym. m(C‚O) Amide m(M–O) m(M–O)
1100sh 1460sh – –
1159sh 1652m 542m 500s
1160sh 1155sh 540m 429s
1152m 1655sh 552m 470s
1160sh 1652m 550m 481s
1158sh 1653m 537m 429s
1144sh 1638m 551m 425s
1125m 1619sh 545s 460s
Figure 2 The FT-IR of Zn–gliclazide complex.
Metal complexes of gliclazide: Preparation, spectroscopic and thermal characterization 113molecules to the metal ions. New bands are found in the spectra
of the complexes in the regions 552–537 and 425–500 cm1,
which are assigned to t(M–O) stretching vibrations of the amide
and sulfonamide-O atoms (Raman et al., 2001).
Therefore, GLZ drug behaves as a neutral bidentate ligand
coordinating to the metal ions via amide-O and enolic sulph-
onamide-OH.
3.4. Electronic spectral studies
Three spin allowed transitions at m1:
4A2gﬁ 4T2g, m2: 4A2gﬁ
4T2g(F), and m3:
4A2gﬁ 4T1g(P) (Cotton et al., 1999) are ob-
served for octahedral Cr(III) complex. The diffused reﬂectance
spectrum of the Cr(III) chelate shows three absorption bands
at 18,770 (m1), 27,450 (m2), and 28,360 cm
1 (m3) which are in
reasonable agreement with those in the literature for octahe-
dral Cr(III) complexes (Cotton et al., 1999).
From the diffused reﬂectance spectrum it is observed that,
the Fe(III) chelate exhibits a band at 22,090 cm1, which
may be assigned to the 6A1gﬁ T2g(G) transition in octahedral
geometry of the complexes (Rosenberg et al., 1999). The
6A1gﬁ 5T1g transition appears to be split into two bands at
16,960 and 15,450 cm1 (Cotton et al., 1999). The spectrum
shows also a band at 27,780 cm1 which may be attributed
to ligand to metal charge transfer. The diffused reﬂectance
spectrum of the Mn(II) complex shows three bands at
15,675, 21,900 and 26,915 cm1 assignable to 6A1gﬁ 4T1g,
6A1gﬁ 4T2g(G) and 6A1gﬁ 4T2g(D) transitions, respectively
(Cotton et al., 1999), which indicates the presence of Mn(II)
complex in tetrahedral structure.
The electronic spectrum of the Co(II) complex with the for-
mula [Co(HL)Cl2(H2O)2] gives three bands at 14,990, 17,420
and 22,250 cm1. The bands observed are assigned to the tran-sitions 4T1g(F)ﬁ 4T2g(F) (m1), 4T1g(F)ﬁ 4A2g(F) (m2) and
4T1g(F)ﬁ 4T2g(P) (m3), respectively, suggesting the presence
of Co(II) complex in octahedral geometry (Zayed et al.,
2007; Cotton et al., 1999). The region at 25,660 cm1 refers
to the charge transfer band.
For Ni(II) complex; [Ni(HL)Cl2(H2O)2]Æ2H2O, the elec-
tronic spectrum displays three bands at m1: 15,790 cm
1:
3A2gﬁ 3T2g; m2: 18,750 cm1: 3A2gﬁ 3T1g(F) and m3:
22,245 cm1: 3A2gﬁ 3T1g(P). The spectrum shows also a band
at 25,047 cm1 which may be attributed to ligand to metal
charge transfer (Zayed et al., 2007; Cotton et al., 1999). The
reﬂectance spectrum of the Cu(II) chelate shows low intensity
shoulder bands centered at 15,790 and 21,870 cm1. Under the
inﬂuence of the tetragonal distortion, the 2Eg and
2T2g states of
the octahedral Cu(II) ion (d9) split such as to cause the three
transitions 2B1gﬁ 2B2g; 2B1gﬁ 2Eg and 2B1gﬁ 2A1g remain
unresolved in the spectra (Manonmani et al., 2000). An intense
peak observed at 25490 cm1 is due to ligand to metal charge
transfer transition. The Zn(II) complex is diamagnetic and tet-
rahedral geometry is proposed for this complex.
3.5. Magnetic susceptibility studies
The room temperature magnetic moment is found to be 4.65
B.M., which corresponds to the presence of Cr(III) in octahe-
dral geometry (Cotton et al., 1999). The observed magnetic
moment value of Fe(III) complex is found to be 5.58 B.M.,
indicating octahedral geometry around the Fe(III) complex
(Zayed et al., 2007; Cotton et al., 1999).
In addition to that, the Mn(II) complex is found to have a
magnetic moment value of 4.62 B.M., which indicates the pres-
ence of Mn(II) complex in tetrahedral structure. The Co(II)
complex is found to have magnetic susceptibility value of
114 G.G. Mohamed et al.5.46 B.M. (Table 1) which is an indicative of octahedral geom-
etry. Meanwhile, the Ni(II) complex has a room temperature
magnetic moment value of 3.74 B.M., which is in the normal
range observed for octahedral Ni(II) complexes (Zayed et al.,
2007; Cotton et al., 1999). The magnetic moment value of
the Cu(II) complex is found to be 1.98 B.M., falls within the
range normally observed for octahedral Cu(II) complexes
(Manonmani et al., 2000).Table 4 Thermodynamic data of the thermal decomposition of GL
Complex Decomp. temp. (C) E* (k Jmol1) A
[Cr(HL)Cl3(H2O)]Æ3H2O 50–120 32.90 1
120–280 53.24 2
280–700 109.1 4
[Mn(HL)Cl2]ÆH2O 30–100 33.25 1
100–300 82.64 3
300–580 142.7 4
580–1000 165.3 3
[Fe(HL)Cl3(H2O)]Æ3H2O 30–120 29.76 2
120–250 67.86 4
200–420 114.2 5
420–650 175.4 6
650–1000 205.6 4
[Co(HL)Cl2(H2O)2] 100–300 52.65 2
300–800 105.2 3
[Ni(HL)Cl2(H2O)2]Æ2H2O 25–110 33.45 1
110–300 85.94 3
300–560 137.4 7
560–900 195.5 6
[Cu(HL)Cl2(H2O)2] 100–250 31.78 1
250–900 82.55 4
[Zn(HL)Cl2] 150–300 40.88 3
300–700 102.3 4
Table 3 Thermal analyses (TG and DTG) data of GLZ drug and
Compound TG range (C) DTGmax (C) na %Found (Ca
Mass loss
[Cr(HL)Cl3(H2O)]Æ3H2O 50–120 88 1 9.38(9.75)
120–280 202 1 40.00(39.09)
280–700 440 1 37.85(37037)
[Mn(HL)Cl2]ÆH2O 30–100 88 1 3.22(3.85)
100–1000 14,249,656 3 81.23(80.94)
[Fe(HL)Cl3(H2O)]Æ3H2O 30–250 67,225 2 32.34(32.17)
250–1000 350,620,867 3 53.22(53.67)
[Co(HL)Cl2(H2O)2] 100–300 215 1 41.58(41.48)
300–800 667 1 44.09(43.11)
[Ni(HL)Cl2(H2O)2]Æ2H2O 30–120 81 1 6.95(6.85)
120–250 198 1 20.18(20.75)
250–600 266,518 2 58.75(58.51)
[Cu(HL)Cl2(H2O)2] 100–900 235,650 2 84.49(83.90)
[Zn(HL)Cl2] 150–300 163 1 15.43(15.45)
300–700 430 1 66.82(66.91)
a n=Number of decomposition steps.3.6. Thermal analyses (TG and DTG)
In the present investigation, theweight losses for each chelate are
calculated within the corresponding temperature ranges. The
obtained data are listed in Table 3. [Cr(HL)Cl3(H2O)]Æ
3H2O complex is thermally decomposed in three decomposition
steps within the temperature range of 50–700 C. The ﬁrstZ metal complexes.
(s1) DS* (k Jmol1) DH* (k Jmol1) DG* (k Jmol1)
.37 · 106 29.85 42.18 54.67
.49 · 1011 65.66 89.86 73.99
.79 · 1013 112.6 138.3 162.4
.77 · 105 34.95 25.15 37.92
.05 · 1010 82.06 67.46 96.02
.18 · 107 116.7 125.1 149.5
.36 · 1011 136.4 160.4 162.7
.63 · 106 24.49 48.22 58.76
.68 · 1011 66.75 85.42 117.4
.05 · 109 116.5 148.7 165.4
.73 · 1013 147.3 177.6 199.3
.89 · 1010 187.2 225.4 242.3
.69 · 109 43.45 45.62 69.79
.49 · 1011 98.29 116.4 141.2
.93 · 1011 33.96 50.48 70.46
.77 · 106 69.17 90.79 131.3
.12 · 1012 102.2 149.2 172.6
.08 · 109 168.4 205.3 243.7
.65 · 108 30.94 45.66 62.66
.09 · 1012 96.47 109.3 139.0
.95 · 108 66.74 72.66 80.96
.79 · 1013 125.4 145.3 168.7
its metal complexes.
lc.) Assignment Metallic residue
Total mass loss
Loss of 3H2O 1/2 Cr2O3
Loss of H2O, HCl, Cl2 and C7H7
87.23(86.21) Loss of C8H13N3O1.5S
Loss of H2O
84.45(84.79) Loss of Cl2 and HL MnO
Loss of Cl2, HC1 and 4H2O
85.56(85.84) Loss of HL 1/2 Fe2O3
Loss of Cl2, C7H12 and 2H2O
85.67(84.59) Loss of C8H9N3O2S CoO
Loss of 2H2O
Loss of 2H2O and 2HCl NiO
85.88(86.11) Loss of HL
84.49(83.90) Loss of Cl2, 2H2O and HL CuO
Loss of Cl2
82.25(82.36) Loss of HL ZnO
Figure 3 (a) TG of Ni–gliclazide complex, and (b) DTG of Ni–gliclazide complex.
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9.75%) within the temperature range 50–120 C may be attrib-
uted to the liberation of three water molecules of hydration.
The activation energy of this dehydration step is found to be
32.90 kJ mol1. The remaining decomposition steps were found
within the temperature range 120–700 C with an estimated
mass loss of 77.85% (calc. 76.46%) can be reasonably accounted
for the removal of coordinated water, HCl, Cl2 and GLZ mole-
cules as gases. The activation energies were listed in Table 4.
The thermogram of [Fe(HL)Cl3(H2O)2]Æ3H2O chelate
shows that the ﬁrst step of decomposition within the tempera-
ture range 30–250 C corresponds to the loss of hydrated and
coordinated water molecules, Cl2 and HCl gases with a mass
loss of 32.34% (calc. 32.17%). The subsequent steps (250–
1000 C) correspond to the removal of the GLZ ligand leaving
metal oxide as a residue. The overall weight loss amounts to
85.56% (calc. 85.84%).
Fig. 3 shows the TGA curve of the Ni(II) complex. The TG
curves of the Mn(II) and Ni(II)-chelates show four stages of
decomposition within the temperature range of 30–1000 and
30–600 C, respectively. The stages at 30–250 C correspond
to the loss of water molecules of hydration and coordination
and anions. The energy of activation for these steps is calcu-
lated using Coats–Redfern method and the data are listed in
Table 4. The subsequent stages involve the loss of ligand mol-
ecules with an overall weight loss amounts to 84.45% (calc.
84.79%) and 85.88% (calc. 86.11%) for Mn(II) and Ni(II)
complexes, respectively.
The TG curves of the Co(II), Cu(II) and Zn(II) chelates
represent two decomposition steps as shown in Table 3. The
two decomposition steps occur within the temperature range
from 100–800, 100–900 and 150–700 C and can be attributed
to the loss of coordinated water, Cl2 and GLZ molecules with
an estimated mass losses of 85.76% (84.59%), 84.49% (calc.
83.90%) and 82.25% (calc. 82.36%) for Co(II), Cu(II) and
Zn(II) complexes, respectively. The energy of activation for
these decomposition steps are listed in Table 4. CoO, CuO
and ZnO are the residues of decomposition.3.7. Kinetic data
The thermodynamic activation parameters of decomposition
processes of dehydrated complexes namely activation energy
(E*), enthalpy (DH*), entropy (DS*) and Gibbs free energy
change of the decomposition (DG*) are evaluated graphically
by employing the Coats–Redfern relation (Coats and Redfern,
1964). The data are summarized in Table 4.
The activation energies of decomposition are found to be in
the range 29.76–205.6 kJ mol1. The high values of the activa-
tion energies reﬂect the thermal stability of the complexes. The
entropy of activation is found to have negative values in all the
complexes which indicate that the decomposition reactions
proceed with a lower rate than the normal ones.
3.8. Structural interpretation
The structures of the complexes of GLZ drug with Cr(III),
Mn(II), Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) ions are con-
ﬁrmed by the elemental analyses, IR, molar conductance, mag-
netic, solid reﬂectance and thermal analyses (TG and DTG)
data. Therefore, from the IR spectra, it is concluded that
GLZ drug behaves as a neutral bidentate ligand coordinated
to the metal ions via the amide-O and sulphonamide-OH.
The molar conductance data, it is found that the complexes
are non-electrolytes. On the basis of the above observations
and from the magnetic and solid reﬂectance measurements,
octahedral and tetrahedral geometries are suggested for the
investigated complexes. As a general conclusion, the complexes
structures can be given as shown in Fig. 4.
3.9. Biological activity
The data show that GLZ drug under investigation and its me-
tal complexes have the capacity of inhibiting the metabolic
growth of the larvae to a different extent. The size of the
inhibition zone depends upon the culture medium, incubation
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Figure 4 Structures of GLZ metal complexes.
Table 5 Effect of GLZ and its complexes on the larvae, pupae
and adults mortalities of the Musca domestica.
Chemical compounds Larval
mortality
Pupal
mortality
Adult
mortality
GLZ – 40 60
[Mn(HL)Cl2]ÆH2O 30 40 30
[Fe(HL)Cl3(H2O)]Æ3H2O 20 40 40
[Ni(HL)Cl2(H2O)2]Æ2H2O 10 80 10
Control – – –
116 G.G. Mohamed et al.conditions, rate of diffusion and the concentration of the anti-
bacterial agent.
The activities of all tested complexes may be explained on
the basis of chelation theory: chelation reduces the polarity
of the metal atom mainly because of the partial sharing of
its positive charge with the donor groups and possible p elec-
tron delocalization within the whole chelate ring. Also, chela-
tion increases the lipophilic nature of the central atom which
subsequently favors its permeation through the lipid layer of
the cell membrane (Caudhary and Singh, 2003).
In testing the biological activity of GLZ and its metal com-
plexes, we used larvae of M. domestica to increase the chance
of detecting antibiotic principles in the tested materials.
3.10. Lethal effects
In focusing the data recorded in Table 5, the potential effects
of the different compounds of GLZ and its complexes (Mn(II),
Fe(III) and Ni(II)) against the treated larvae of M. domestica
are clear. Larval mortality is found to be 30%, 20% and
10% due to the effect of Mn(II), Fe(III) and Ni(II) complexes,
respectively, whereas GLZ has no effect. While the three com-
pounds; GLZ, Mn(II) and Fe(III), are found to cause 40% and
Ni(II) complex is found to cause 80% of the pupal mortality.
The higher adult mortality is found to be 60%, 40%, 30% and10% by the effect of GLZ, Fe(III), Mn(II), and Ni(II) com-
plexes, respectively, in comparison to 0.0% mortality of con-
trol insect (Table 5).
3.11. Morphogenic effects
Typical application of GLZ and its complexes on the different
developmental stages of M. domestica resulted in different
morphogenic abnormalities of pupation and adult emergence.
On the other hand, the pupation program is impaired in differ-
ent degrees by the various compounds. This effect is approxi-
mately a compound-dependent. Contrary to the previous fact,
the GLZ drug has no effect on the larvae. On the other hand,
the larval-pupal and adult deformations are increased by the
effect of Mn(II), Fe(III) and Ni(II) complexes. The majority
of the observed morphogenic effects represented as shrinking
of skin with black colour and larval-pupal intermediate.
The toxicity effect ofGLZ, seems to be due to the penetration
of the different chemical compounds, is inversely proportional
to the thickness of the insect cuticle. These results are in good
agreementwith those previously published (Bruck, 1979;Nassar
et al., 2008; Samarasekera et al., 2004). It is clear from the data
obtained that the larval instar was more tolerant to the chemical
compounds than the pupal and adult stages. This can be attrib-
uted to insect size (Ikeda et al., 1979).On the other hand, toxicity
effects ofGLZand its complexes can be attributed also to the de-
crease of blood glucose level in insect (Amin et al., 2004). Sul-
phonylurea drugs such as GLZ were found to inhibit ﬂuid
secretion and metabolism of Drosophila melanogaster ﬂy (Evan
et al., 2005). The insecticidal efﬁcacy on 3rd larval instar and
adult fecundity ofM. domestica was due to the metabolism dis-
turbance by the effect ofTrigonella foenum extracts (Adel Halim
andMorsy, 2006). In comparison, the variable effects ofGLZon
the different developmental stages ofM.domestica is found to be
strengthen resistance for some complexes.
The complexes that found to produce morphological abnor-
malities can be attributed to their effects on total protein content
Metal complexes of gliclazide: Preparation, spectroscopic and thermal characterization 117which inhibited the cholinesterase, esterase enzymes and alka-
line acid phosphatases in the blood of the different stages of
M. domestica (Ghoneim et al., 1992). Typical application of
the GLZ complexes on the larval instars of the M. domestica,
in the present study, resulted in pronouncedly prohibition of
the pupation and adult emergence. It may be considered as a re-
sult of the haemolymph ecdysteroids. In otherwords,GLZ com-
plexes are classiﬁed in the category of chitin inhibitors.
The possible morphogenic action of GLZ on the larvae, pu-
pae and adult eclosion programmes, available data in the pres-
ent study unambiguously prevailed increased deformity,
approximately, by the decreasing dose-level of M. domestica
(Nassar, 1995), M. stabulans (Ghoneim et al., 1992; Nassar,
1995) and Rhynchophorus ferrugineus (Ghoneim et al., 2007;
Nassar et al., 2008).References
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